Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Trial for Treatment Refractory Trigeminal Neuralgia

ClinicalTrials.gov ID: NCT03941834

Public ClinicalTrials.gov record NCT03941834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BHV3000-202: Phase 2: A Double-Blind, Placebo Controlled, Crossover Trial of BHV-3000 (Rimegepant) for Treatment Refractory Trigeminal Neuralgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater reduction in the average Numeric Pain Rating Scale between the two-week treatment phases.

Study identification

NCT ID
NCT03941834
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
65 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2019 (Actual)
Primary completion
May 11, 2023 (Actual)
Completion
May 11, 2023 (Actual)
Last update posted
Jun 10, 2024

2019 – 2023

United States locations

U.S. sites
20
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Gilbert Neurology Partners, PLLC/CCT Research Gilbert Arizona 85297 —
Center for Neurohealth DBA Kaizen Brain Center La Jolla California 92037 —
Imaging Clinic at Stanford Neuroscience Health Center Palo Alto California 94304 —
Stanford Hoover Pavilion Palo Alto California 94304 —
Stanford Neuroscience Health Center- SNHC Pharmacy Palo Alto California 94304 —
Stanford Neuroscience Health Center Palo Alto California 94304 —
Stanford University- CAM Building Stanford California 94305 —
SouthCoast Research Center Miami Florida 33136 —
Ochsner Baptist Medical Center New Orleans Louisiana 70115 —
Johns Hopkins Clinical Outpatient Center Baltimore Maryland 21287 —
Johns Hopkins ICTR Clinical Research Unit (CRU) Baltimore Maryland 21287 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Dent Neurosciences Research Center Amherst New York 14226 —
Neurological Surgery Practice of Long Island PLCC Lake Success New York 11042 —
Neurological Surgery Lake Success New York 11042 —
Premier Cardiolog Consultants Lake Success New York 11042 —
Premier Cardiolog Consultants New Hyde Park New York 11042 —
Premier Cardiology Consultants New Hyde Park New York 11042 —
North Suffolk Neurology, PC Port Jefferson Station New York 11776 —
Neurology Diagnostics Inc. Dayton Ohio 45459 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03941834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2024 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03941834 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →